Gozde Ecem Cecikoglu

Gozde Ecem Cecikoglu

Auto-generated profile, based on publicly available information

Gozde Ecem Cecikoglu

Department of Pathology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in The Prostate
Verified
Journal Article
Closed access
OKOzgur Kazan
Ozgur Kazan
NGNesrin Gunduz
Nesrin Gunduz
GKGozde Kir
Gozde Kir
AIAyberk Iplikci
Ayberk Iplikci
MDMahmut B. Dogan
Mahmut B. Dogan
AYAsif Yildirim
Asif Yildirim

26 July 2022 in Andrologia
Verified
Journal Article
Closed access
OKOzgur Kazan
Ozgur Kazan
GKGozde Kir
Gozde Kir
MCMeftun Culpan
Meftun Culpan
GCGozde Ecem Cecikoglu
Gozde Ecem Cecikoglu
GAGokhan Atis
Gokhan Atis
AYAsif Yildirim
Asif Yildirim

1 January 2023 in Urology Research and Practice
Verified
Journal Article
Open access
ÖEÖzgür Efiloğlu
Özgür Efiloğlu
MÇMehmet Çağlar Çakıcı
Mehmet Çağlar Çakıcı
GKGözde Kır
Gözde Kır
AIAyberk İpLikçi
Ayberk İpLikçi
TTTurgay Turan
Turgay Turan
AYAsıf Yıldırım
Asıf Yıldırım
Objective: Bladder cancer is a heterogeneous entity characterized by a wide range of different morphologies. The aim of this study was to investigate the prognostic effect of bladder tumor with variant histology that is treated with radical cystectomy on oncological outcomes. Methods: One hundred eighty-six patients who underwent radical cystectomy between September 2001 and June 2020 were included in the study. The patients were divided into 2 groups variant histology group (n = 54) and transitional cell cancer group (n = 132). Clinicopathologic data were compared between the two groups. Results: The groups were similar in terms of demographic characteristics. In the mul- tivariate analysis of cancer-specific survival in transitional cell cancer against variant histology, high-grade detection of primary transurethral bladder tumor pathology, cystectomy pT, cystectomy positive lymph node, and positive surgical margin in cys- tectomy were determined to be statistically significant. Diagnosis of pT2 and high grade of primary transurethral bladder tumor pathology, cystectomy ≥ pT3, cystec- tomy positive lymph node, and positive surgical margin in cystectomy were statis- tically significant in multivariate analysis of overall survival. Cancer-specific survival time was estimated at 65.1 ± 8.3 months for variant histology and 134.2 ± 10.4 months for transitional cell cancer (P=.004). The estimated overall survival time was 61.9 ± 8.0 months in variant histology and 119.0 ± 9.8 months in transitional cell cancer (P = .014). Conclusion: Pathological features and prognosis of bladder cancer with variant histol- ogies are worse than those of pure urothelial bladder cancer. Overall survival and can- cer-specific survival are shorter in bladder cancer with variant histology than in pure urothelial bladder cancer. Following the diagnosis of variant histology in transurethral bladder tumor, poor prognosis must be considered in the treatment plan. Cite this article as: Efiloğlu Ö, Çağlar Çakıcı M, Kır G, et al. The impact of histological variants on oncological outcomes in patients with muscle invasive bladder cancer treated with radical cystectomy. Urol Res Pract. 2023;49(4):246-252.

28 November 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
MCMeftun Culpan
Meftun Culpan
AIAyberk Iplikci
Ayberk Iplikci
GKGozde Kir
Gozde Kir
GCGozde Ecem Cecikoglu
Gozde Ecem Cecikoglu
GAGokhan Atis
Gokhan Atis
AYAsif Yildirim
Asif Yildirim
OBJECTIVE: We aimed to investigate the impact of tumor necrosis in non-muscle invasive bladder cancer on patients' recurrence and progression rates and survival outcomes.METHODS: This study was conducted retrospectively in a single tertiary center in Turkey. Medical records of patients who underwent transurethral resection of the bladder tumor between January 2016 and January 2021 were reviewed. Patients with pTa and pT1 non-muscle invasive bladder cancer who had undergone complete resection were included in our study. All pathological specimens were reevaluated for the presence of tumor necrosis.RESULTS: A total of 287 patients (244 males and 43 females) were included in our study. Of them, 33 (11.5%) patients had tumor necrosis. The rates of multiple and large tumors (>3 cm) were higher in patients with tumor necrosis (p=0.002 and p<0.001, respectively). Tumor necrosis was associated with higher rates of pT1 diseases (p<0.001), high-grade tumors (p<0.001), and the presence of lymphovascular invasion (p=0.007). The mean recurrence-free survival of patients with tumor necrosis was 42.3 (4.6) months, and the recurrence-free survival of patients without tumor necrosis was 43.5 (1.8) months (p=0.720). The mean progression-free survival of patients with tumor necrosis was 43.1 (4.6) months, and the progression -free survival of patients without tumor necrosis was 58.4 (0.9) months. In log-rank analysis, there was a statistically significant difference between patients with and without tumor necrosis in terms of progression-free survival (p<0.001).CONCLUSION: In this study, we demonstrated that patients with non-muscle invasive bladder cancer and tumor necrosis in pathological specimens have shorter progression-free survival and more adverse pathological features.

1 January 2021 in Turkiye Klinikleri Journal of Case Reports
Verified
Journal Article
Open access
PDF file
BŞBengü Çobanoğlu Şi̇mşek
Bengü Çobanoğlu Şi̇mşek
GCGözde Ecem Ceci̇koğlu
Gözde Ecem Ceci̇koğlu
EDEbubekir Durmuş
Ebubekir Durmuş
USUmut Perçem Orhan Söylemez
Umut Perçem Orhan Söylemez
Immunoglobulin G4-related diseases (IgG4-RDs) are immune-mediated, fibroinflammatory conditions that are characterised by affected organ enlargement, lymphocyte, plasma cell infiltration (determined with IgG4-positive plasma cells) and serum IgG4 level elevation. When the disease affects ocular adnexal tissues (such as the lacrimal gland, extraocular muscles, trigeminal nerve branches and orbital fat), it is called IgG4-related ophthalmic disease (IgG4-ROD). The diagnosis of IgG4-ROD is made by physical examination, biochemical findings and histopathological evaluation. It is characterized by elevated serum IgG4 levels and distinctive histopathological features, including IgG4+ plasma cell infiltration, the presence of fibrosis in the storiform pattern and the presence of a dense lymphoplasmacytic inflammatory infiltrate, including eosinophils. It is rare in the ocular region and cause diagnostic confusion. There is a high probability of misdiagnosis when the disease is not recognized. Here, a rare case of eye involvement is presented and IgG4-RDs are discussed with the literature.

24 June 2025 in Urology Research and Practice
Verified
Journal Article
Open access
KTKenan Toprak
Kenan Toprak
MCMehmet Gokhan Culha
Mehmet Gokhan Culha
HKHuseyin Ozgur Kazan
Huseyin Ozgur Kazan
AIAyberk Iplikci
Ayberk Iplikci
GKGozde Kir
Gozde Kir
AYAsif Yildirim
Asif Yildirim
Objective: Sorcin, a signaling molecule, has recently emerged as a significant focus within cancer research. This study aimed to compare histopathology results with serum sorcin level and tissue sorcin immunohistochemical expression in patients who underwent radical prostatectomy (RP). Methods: A total of 81 patients who underwent RP between December 2017 and June 2019 due to prostate cancer (PCa) and had not received any previous treatment were included in the study. Patients attended regular follow-up appointments for at least 24 months. In order to compare serum sorcin levels, the control group con sisted of 67 healthy men. Demographic data of participants were recorded. In the PCa group, pathology data from both Transrectal ultrasound-guided biopsy and RP were documented. Results: Prostate-specific antigen (PSA) and sorcin levels of PCa patients were found to be higher than the control group (P < .001, P = .02). In the comparison of sorcin lev els and sorcin staining percentages of PCa patients with histopathological and clinical findings; while sorcin levels were found to be higher in patients with positive lymph nodes (P = .018) and with biochemical recurrence (P = .049), no significant difference was found in any histopathological finding in terms of sorcin staining percentages. In an receiver operating characteristic curve analysis calculation for sorcin levels in PCa patients, AUC = 0.563 and when the cut-off value was taken as 0.415 ng/mL, 59.3% sen sitivity 60.1% specificity was determined. Conclusion: Sorcin was found to be higher in PCa compared to healthy males. In addi tion, high International Society of Urological Pathology grade groups were observed in patients with high sorcin levels. Cite this article as: Toprak K, Culha MG, Kazan HO, et!al. Biochemical and histological characterization of sorcin overexpression in patients who underwent radical prostatectomy. Urol Res Pract. 2025;51(3):105-110.